View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200, Tumor Biomarker Defined, neoadjuvant
Protocol-ID: 2956 V1.0 (Mini), PEMB200, Tumor Biomarker Defined, neoadj.Indication(s)
- Tumor Biomarker Defined
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 07.07.2025